A total of 171 institutions have reported a stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) as of December 2025, according to recent 13F filings with the SEC.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 31 Dec, 2025 | 17,687,772 | 0 | 0.00% | $62,084,080.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 8,544,423 | 1,652,219 | 23.97% | $29,990,925.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 7,906,071 | 791,700 | 11.13% | $27,750,309.00 |
| CITIGROUP INC | 31 Dec, 2025 | 5,246,349 | 5,235,924 | 50,224.69% | $18,414,685.00 |
| MORGAN STANLEY | 31 Dec, 2025 | 3,941,377 | 294,338 | 8.07% | $13,834,233.00 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 2,992,735 | -850,598 | -22.13% | $10,504,500.00 |
| Monaco Asset Management SAM | 31 Dec, 2025 | 2,987,296 | 95,035 | 3.29% | $10,485,409.00 |
| Newtyn Management, LLC | 31 Dec, 2025 | 2,650,000 | 147,137 | 5.88% | $9,301,500.00 |
| D. E. Shaw & Co., Inc. | 31 Dec, 2025 | 2,640,518 | 450,768 | 20.59% | $9,268,218.00 |
| MAVERICK CAPITAL LTD | 31 Dec, 2025 | 2,513,110 | -5,955,234 | -70.32% | $8,821,016.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Dec, 2025 | 2,131,929 | 522,247 | 32.44% | $7,483,071.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 2,120,269 | 205,715 | 10.74% | $7,443,495.00 |
| TWO SIGMA ADVISERS, LP | 31 Dec, 2025 | 1,864,651 | 68,900 | 3.84% | $6,544,925.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Dec, 2025 | 1,784,921 | -1,785,470 | -50.01% | $6,265,073.00 |
| STATE STREET CORP | 31 Dec, 2025 | 1,700,631 | -44,679 | -2.56% | $5,969,215.00 |
| MPM BioImpact LLC | 31 Dec, 2025 | 1,586,076 | -2,317,305 | -59.37% | $5,567,127.00 |
| JPMORGAN CHASE & CO | 31 Dec, 2025 | 1,475,624 | -621,409 | -29.63% | $5,179,442.00 |
| CITADEL ADVISORS LLC | 31 Dec, 2025 | 1,299,991 | -370,936 | -22.20% | $4,562,968.00 |
| Opaleye Management Inc. | 31 Dec, 2025 | 955,000 | 955,000 | 0.00% | $3,352,050.00 |
| GOLDMAN SACHS GROUP INC | 31 Dec, 2025 | 936,594 | -334,499 | -26.32% | $3,287,444.00 |